SNDL, Inc. (SNDL)
1.45
-0.02
(-1.36%)
USD |
NASDAQ |
May 22, 13:49
SNDL Cash from Investing (Quarterly) : -8.286M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Tilray Brands, Inc. | 28.63M |
| CannaPharmaRx, Inc. | 0.00 |
| Pharmagreen Biotech, Inc. | -- |
| Lexaria Bioscience Corp. | -0.0539M |
| InMed Pharmaceuticals, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 2.538M |
| Cash from Financing (Quarterly) | -13.71M |
| Free Cash Flow | 40.82M |
| Free Cash Flow Per Share (Quarterly) | 0.0024 |
| Free Cash Flow to Equity (Quarterly) | 3.937M |
| Free Cash Flow to Firm (Quarterly) | 2.024M |
| Free Cash Flow Yield | 10.77% |